about
Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.Review on the current use of antipsychotic drugs in children and adolescents.Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT).The ‑α3.7 deletion in α‑globin genes increases the concentration of fetal hemoglobin and hemoglobin A2 in a Saudi Arabian population.Optimal pcr primers for rapid and accurate detection of Aspergillus flavus isolates.Rhabdomyolysis Reported for Children and Adolescents Treated with Antipsychotic Medicines: A Case Series AnalysisAssessment of patient safety culture: a nationwide survey of community pharmacists in KuwaitSynthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking StudyEnvironmental and Genetic Factors in Autism Spectrum Disorders: Special Emphasis on Data from Arabian StudiesSynthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole DerivativesThe rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switchingSynthesis of benzothiazole derivatives as a potent α-glucosidase inhibitorSynthesis of novel quinoline-based thiadiazole, evaluation of their antileishmanial potential and molecular docking studiesGenetic disorder prenatal diagnosis and pregnancy termination practices among high consanguinity population, Saudi ArabiaSynthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico
P50
Q37637624-B229BCDD-F45E-4339-AC4E-C90C6C12DBDBQ37902788-969842CD-7EFE-4447-B81E-1B179423766EQ38092009-8108B3FA-A082-48BF-9294-7A67DD8B2106Q49564594-E10B4417-909C-4F8C-8F4A-C0162CD09447Q50014241-E01B9440-7D6E-421B-A53C-6EE6EA3FA4ADQ50086534-B0009F05-D4F8-404C-BDCF-772C02021236Q57273979-D1E13F4A-B55A-4B42-A6B2-A82195BB1B45Q59329550-2337E04B-75A6-48BF-B219-574FAD1A9BA9Q64099058-0E049105-F337-4BA6-A7EE-FCABC0DAAFAEQ64108280-3070D862-7FAB-44D3-9F9E-E44FC676D20CQ64116801-9595436F-7CCC-4499-B76B-F17BC2B68B75Q64246815-29C4010D-4B9C-48E9-A5AB-ABF9BF4B4503Q90837756-B2AC88A4-8466-4827-B300-EB8F5C6EE750Q90866201-BF449573-B0A7-4F33-A57B-1F77EBA4A811Q91386408-2446EC6F-78FD-4B2C-82B8-09BCA0D8E553Q91435829-1FAE3396-DBAA-441B-87A0-749F175B105A
P50
description
researcher, ORCID id # 0000-0002-7049-3563
@en
wetenschapper
@nl
name
Noor B Almandil
@ast
Noor B Almandil
@en
Noor B Almandil
@es
Noor B Almandil
@nl
type
label
Noor B Almandil
@ast
Noor B Almandil
@en
Noor B Almandil
@es
Noor B Almandil
@nl
prefLabel
Noor B Almandil
@ast
Noor B Almandil
@en
Noor B Almandil
@es
Noor B Almandil
@nl
P106
P1153
43061058200
P31
P496
0000-0002-7049-3563